Science & Health

The Aramont Fellowship Fund for Emerging Science Research provides vital support for early-career faculty and postdoctoral scholars across four Harvard Schools. Responding to the urgent need for research support after federal funding cuts, a generous new gift from the foundation doubles the size of this year’s cohort from the previous year.

A discovery in a Harvard lab may open a new path for treating certain cardiovascular diseases. By re-engineering the hormone relaxin so it can stay longer in the body, researchers created a therapeutic approach that could help counter fibrosis and improve heart and vascular function for patients with limited treatment options. 

From uncovering how the immune system fights infection to developing new treatments for cancer, autoimmune diseases, and viral threats, Harvard researchers are advancing knowledge that strengthens global health, supports prevention, and improves lives for communities everywhere.

Harvard scientists have invented a new way to 3D print soft robots that can bend and grasp, laying the groundwork for applications ranging from surgical tools to assistive devices.

Harvard stem cell biologists have uncovered a method to grow the brain cells affected by ALS and spinal cord injuries, opening new paths for research and treatment.

Harvard researchers are redesigning robotic joints to improve efficiency and performance, paving the way for safer medical devices and more accessible assistive technologies.

For Maria Perez-Matos PhD ’25, the question of aging is not just about adding years to life, but about adding healthy years. She hopes her research on longevity will help ensure that individuals can experience a good quality of life until their final day.

Researchers at the Broad Institute, Harvard Medical School, Mass General Brigham, and Johnson & Johnson Innovative Medicine have developed small-molecule drug candidates that could potentially treat Crohn’s disease and other inflammatory bowel diseases.

A new study reveals five genetic patterns common to 14 major psychiatric conditions, offering fresh insights that could help improve precision in diagnosis and treatment.

In a first-in-human trial, a Harvard-developed biomaterial-based cancer vaccine proved safe and activated patients’ immune responses, marking a step forward for personalized cancer treatment.